SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A strong third-quarter report and raised revenue outlook, driven by demand for Mounjaro and Zepbound, are fueling Lillys breakout and a wave of analyst upgrades. Traders are also weighing the growth outlook against a lower profit forecast tied to acquisition-related R&D charges, weaker-than-expected Foundayo sales and concerns about valuation.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Recurring Schwab and thinkorswim login, app, and trading glitches are drawing widespread complaints, with some traders saying they may move their accounts or seeking compensation. The discussion also reflects frustration with SCHWs decline, alongside debate over whether the selloff is a buying opportunity.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Soquelitinibs atopic-dermatitis data and company presentation are driving discussion: bullish traders view the early results as encouraging, while skeptics say the presentation fell short of expectations and left safety and efficacy questions unresolved amid a sharp selloff.

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through North America and International Personal Care segments. The North America segment consists of products encompassing each of daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care, and Feminine Care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Dallas, TX.

Kimberly-Clark Corp.

Kimberly-Clark is drawing attention after preliminary Q3 results topped expectations and management reaffirmed its outlook; traders also point to a China product-testing update as easing Huggies-related concerns and to progress on the Kenvue acquisition. Bulls cite the earnings report, potential merger efficiencies and defensive-staples demand, while skeptics remain wary of deal execution and the stocks pullback.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention ahead of anticipated Q3 results and November topline data from its Phase 3 QUILT-2.005 trial of ANKTIVA plus BCG in BCG-nave bladder cancer; the company has said an sBLA submission is planned for Q4. Many traders see the readout and possible sales growth as catalysts for expanding ANKTIVAs market, while others question the near-term revenue outlook and debate the stocks weakness, short interest, and volatility.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders weigh Middle East supply risksespecially reported attacks and threats around the Strait of Hormuzagainst possible US-Iran negotiations that could ease oil prices. Bulls cite disrupted flows and escalation risks, while bears argue that a deal or de-escalation could quickly unwind the geopolitical premium.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake is drawing attention as traders await the FDAs decision on whether to accept its sonelokimab application for hidradenitis suppurativa and what review timeline it will receive. The community is split between optimism about the drug and upcoming regulatory milestone and concern over approval risk, commercialization plans, and continued weakness in biotech shares.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargos third-quarter results are driving discussion: earnings beat expectations, but revenue and net interest income came in light, and higher credit-loss provisions added to concerns about lending performance. Traders are split between viewing the profit and loan growth as signs of strength and seeing the stocks decline as a reaction to the weaker revenue details.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reached its 80th death event, starting database lock, unblinding and final overall-survival analysis, with topline results expected in Q4. Traders are divided over whether the long trial duration and continued GPS dosing point to a benefit or whether uncertainties around the control arm and dosing changes weaken the case; the shares have fallen since the milestone announcement.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

Jason Fews Bloomberg interview has focused attention on a possible delay to the Texas project agreement and the lack of a quantitative update on FuelCell Energys manufacturing ramp, prompting criticism of managements transparency and execution. Some traders remain optimistic about data-center power demand and the companys prospects, but debate whether those opportunities can translate into delivered projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SKHY anyone bought at Friday is going to be a bagholder for maybe 1-3 years or maybe forever!!

StockTwits for iOS

SK Hynix Inc - ADR

$SKHYV anyone bought at Friday is going to be a bagholder for maybe 1-3 years or maybe forever!!